Photochemical Internalization of siRNA for Cancer Therapy.
Lamiaa Mohamed Ahmed AliMagali Gary-BoboPublished in: Cancers (2022)
In the race to design ever more effective therapy with ever more focused and controlled actions, nanomedicine and phototherapy seem to be two allies of choice. Indeed, the use of nanovectors making it possible to transport and protect genetic material is becoming increasingly important. In addition, the use of a method allowing the release of genetic material in a controlled way in space and time is also a strategy increasingly studied thanks to the use of lasers. In parallel, the use of interfering RNA and, more particularly, of small-interfering RNA (siRNA) has demonstrated significant potential for gene therapy. In this review, we focused on the design of the different nanovectors capable of transporting siRNAs and releasing them so that they can turn off the expression of deregulated genes in cancers through controlled photoexcitation with high precision. This mechanism, called photochemical internalization (PCI), corresponds to the lysosomal leakage of the cargo (siRNA in this case) after destabilization of the lysosomal membrane under light excitation.
Keyphrases
- cancer therapy
- gene therapy
- drug delivery
- genome wide
- poor prognosis
- coronary artery disease
- percutaneous coronary intervention
- acute myocardial infarction
- atrial fibrillation
- heart failure
- dna methylation
- acute coronary syndrome
- binding protein
- hyaluronic acid
- st elevation myocardial infarction
- mesenchymal stem cells
- bone marrow
- risk assessment
- transcription factor
- young adults
- human health
- left ventricular
- genome wide identification
- fluorescent probe
- decision making